|
|
|
|
Renal Cell Cancer
MethylGene Announces Year-End 2005 Financial Results and Updates ... Mar 9, 2006
CCNMatthews (press release), ...proprietary demethylating agent, is near completion of the first step of the Phase II trial in combination with interferon alpha in renal cell cancer patients. ...
Recruitment Goal for Phase 1 Study Reached Sooner Than Planned Mar 7, 2006
PharmaLive.com (press release), ...cancers, today announced that the recruitment of patients for its initial Phase 1 clinical study of a potential vaccine against renal cell cancer (IMA901) has ...
WILEX Appoints Members to its Medical Advisory Board for Rencarex ... Mar 1, 2006
PharmaLive.com (press release), Efficacy in RCC) evaluates Rencarex (WX-G250) versus placebo in the adjuvant setting in more than 600 patients with non-metastatic renal cell cancer at high ...
Avastin® Adriamycin Combination for Soft Tissue Sarcoma Mar 8, 2006
Cancer Consultants (press release), ...for the past 3-4 years has shown significant activity in the treatment of several tumors, including breast, lung, colon and renal cell cancer, when combined ...
Central Minnesota Short On Judges 25 Jan 2006
WCCO, Morrison County Judge Thomas Godzala announced Monday that he will be on leave for several months to battle renal cell cancer, the most common type of kidney ...
SIXTH ANNUAL REPORT: FUTURE BLOCKBUSTERS Dec 30, 2005
Med Ad News (subscription), 2006. Nexavar is being tested in the largest randomized, placebo-controlled trial ever conducted in advanced renal cell cancer. ...
New treatment saves cancer victims Dec 23, 2005
East Texas Review, ...was disbelief, then fear. She was diagnosed with Stage 4 Renal Cell Cancer, which is as ominous as it sounds. Her body had been ...
New Treatment For Kidney And Skin Cancer Dec 27, 2005
KLTV, Susan Griffis of Athens was diagnosed with progressive renal cell cancer-- also known as kidney cancer, in July of 2004. "The urologist ...
Tiffin woman donates hair, backs Browns to honor deceased sibling Jan 16, 2006
Tiffin Advertiser Tribune, Doug Nusbaum. Nearly six years ago, Nusbaum died of renal cell cancer, a rare variety that affects the kidneys. Canterbury said ...
Immutep initiates Phase I clinical trial in renal cell cancer Nov 22, 2005
Biotech Intelligence (press release), Orsay, 22 November 2005 - Immutep SA announced today that it has initiated a Phase I clinical trial of its lead product ImmuFact(R) IMP321 in metastatic renal ...
Immutep Initiates Phase I Clinical Trial in Renal Cell Cancer Nov 22, 2005
PharmaLive.com (press release), ORSAY, France, Nov. 22, 2005 - Immutep SA announced today that it has initiated a Phase I clinical trial of its lead product ImmuFact ...
ZymoGenetics Highlights Development Programs at Analyst & Investor ... Dec 8, 2005
PR Newswire (press release), In IL-21 Phase 2 clinical studies, ZymoGenetics is planning to examine renal cell cancer and Novo Nordisk will evaluate metastatic melanoma. ...
immatics launches Phase I clinical study on cancer vaccine IMA901 ... Nov 29, 2005
PharmaLive.com (press release), Under the study, some two dozen patients suffering from advanced stages of renal cell cancer will be treated in six locations in Germany, the United Kingdom ...
GlaxoSmithKline Presents Rapidly Expanding Pipeline of Oncology ... Nov 30, 2005
Finanzen.net, ...of VEGF inhibitors, GSK is pursuing an aggressive clinical development program for pazopanib with global phase III trials in renal-cell cancer expected to ...
MethylGene Reports Encouraging Preliminary Clinical Results for ... Dec 8, 2005
CCNMatthews (press release), ...azacitidine. MG98 has entered a randomized two-step Phase II combination trial with interferon alpha in metastatic renal cell cancer. ...
NEWS SNAP: GSK Sees 4 Drugs In Phase 3 In '06 - 2 Nov 30, 2005
Business Online, GlaxoSmithkline is also planning to soon start phase III studies for pazopanib, a compound that prevents tumor growth, for the treatment of renal cell cancer. ...
Four candidates to start Phase III trials in 2006 Nov 30, 2005
MarketWatch It added that it is pursuing an aggressive clinical development program for Pazopanib, with global Phase III trials in renal-cell cancer expected to begin ...
Ziopharm's anticancer drug shows potential Nov 18, 2005
Pharmaceutical Business Review One patient with metastatic renal cell cancer responded with complete resolution of brain metastasis and overall stable disease. ...
Lorus and Ohio State University to collaborate on acute myeloid ... Sep 7, 2005
In addition to the clinical trial in renal cell cancer described above, GTI-2040 is currently the subject of a Clinical Trials Agreement with the United States ... Canada NewsWire (press release),
'Cowboy' wants to see canyon before he dies Sep 7, 2005
...come true. Loran has metastatic renal cell cancer that started in his kidneys and has spread to his bones, blood and lungs. The ... Brown County Democrat,
Gene Expression of Kidney Cancers May Aid in Diagnosis Aug 29, 2005
Renal cell cancer (RCC) is the most common type of kidney cancer. ... Gene signatures of progression and metastasis in renal cell cancer. Clinical Cancer Research. ... Cancer Consultants (press release),
Pfizer files with FDA for Sutent approval Aug 10, 2005
In two Phase II trials in metastatic renal cell cancer, about 40 percent of patients showed a response to Sutent treatment and tumor progression was delayed in ... Science Daily (press release)
MethylGene Announces Second Quarter 2005 Results Aug 11, 2005
...on the initial six patients enrolled in a Phase II clinical trial for MG98 (a demethylating agent) in combination with interferon alpha, in renal cell cancer. ... Business Wire (press release),
Pharmacyclics Reports Fourth Quarter and Fiscal 2005 Financial ... Aug 18, 2005
...anti-tumor activity as a single agent in advanced recurrent chronic lymphocytic leukemia (CLL), non-Hodgkin's B-cell lymphomas, and renal cell cancer. ... Yahoo News (press release)
Bayer and Onyx Announce FDA Acceptance of New Drug Application for ... -- Sep 13, 2005
Results from the study -- the largest randomized, placebo-controlled trial ever conducted in advanced renal cell cancer -- were presented in May at the 41st ... / PR Newswire (press release),
Lorus and Ohio State University to collaborate on acute myeloid ... -- Sep 7, 2005
In addition to the clinical trial in renal cell cancer described above, GTI-2040 is currently the subject of a Clinical Trials Agreement with the United States ... / Canada NewsWire (press release),
Gene Expression of Kidney Cancers May Aid in Diagnosis -- Aug 29, 2005
Renal cell cancer (RCC) is the most common type of kidney cancer. ... Gene signatures of progression and metastasis in renal cell cancer. Clinical Cancer Research. ... / Cancer Consultants (press release),
Pharmacyclics Reports Fourth Quarter and Fiscal 2005 Financial ... -- Aug 18, 2005
...anti-tumor activity as a single agent in advanced recurrent chronic lymphocytic leukemia (CLL), non-Hodgkin's B-cell lymphomas, and renal cell cancer. ... / Yahoo News (press release)
'Cowboy' wants to see canyon before he dies -- Sep 7, 2005
...come true. Loran has metastatic renal cell cancer that started in his kidneys and has spread to his bones, blood and lungs. The ... / Brown County Democrat,
Lorus and Ohio State University to collaborate on acute myeloid ... Sep 7, 2005
In addition to the clinical trial in renal cell cancer described above, GTI-2040 is currently the subject of a Clinical Trials Agreement with the United States ... Canada NewsWire (press release),
'Cowboy' wants to see canyon before he dies Sep 7, 2005
...come true. Loran has metastatic renal cell cancer that started in his kidneys and has spread to his bones, blood and lungs. The ... Brown County Democrat,
Gene Expression of Kidney Cancers May Aid in Diagnosis Aug 29, 2005
Renal cell cancer (RCC) is the most common type of kidney cancer. ... Gene signatures of progression and metastasis in renal cell cancer. Clinical Cancer Research. ... Cancer Consultants (press release),
Pfizer files with FDA for Sutent approval Aug 10, 2005
In two Phase II trials in metastatic renal cell cancer, about 40 percent of patients showed a response to Sutent treatment and tumor progression was delayed in ... Science Daily (press release)
MethylGene Announces Second Quarter 2005 Results Aug 11, 2005
...on the initial six patients enrolled in a Phase II clinical trial for MG98 (a demethylating agent) in combination with interferon alpha, in renal cell cancer. ... Business Wire (press release),
Pharmacyclics Reports Fourth Quarter and Fiscal 2005 Financial ... Aug 18, 2005
...anti-tumor activity as a single agent in advanced recurrent chronic lymphocytic leukemia (CLL), non-Hodgkin's B-cell lymphomas, and renal cell cancer. ... Yahoo News (press release)
Retinoic Acid Modestly Improves Survival of Metastatic Renal Cell ... -- Jun 24, 2005
Researchers affiliated with the European Organization for Research and Treatment of Cancer (EORTC) have reported that the addition of 13-cis-retinoic acid to ... / Cancer Consultants (press release),
Sorafenib® May be Available for Patients with Advanced Renal Cell ... -- Jun 14, 2005
Renal cell cancer is a malignancy involving these tubules of the kidney. ... Stem cell transplantation is also being evaluated for renal cell cancer. ... / Cancer Consultants (press release),
Radiofrequency Ablation Promising for Small Renal Tumors -- Jun 28, 2005
...remove waste and make urine. Renal cell cancer is a malignancy involving these tubules of the kidney. Treatment for renal cell carcinoma ... / Cancer Consultants (press release),
Rosenfeld, former 'News' editor, dies -- Jul 1, 2005
...followed. In 1994, he bravely wrote about his experience. Death came from complications of renal cell cancer, his family said. He ... / Dayton Daily News (subscription),
Inhaled Interleukin-2 (IL-2) Improves Survival in Advanced Kidney ... -- Jun 9, 2005
Renal cell cancer (RCC) is an uncommon form of cancer that is most often characterized by the presence of cancer cells in the lining of the filtration tubules ... / Cancer Consultants (press release),
New Safety Information on the Use of DEPO-PROVERA ... -- Jun 30, 2005
...outside of the uterus), treatment of recurrent and/or metastatic endometrial cancer (cancer of the lining of the uterus) or renal cell cancer (kidney cancer ... / Canada NewsWire (press release),
A father's blessing: Cancer fight gives meaning to special day -- Jun 20, 2005
Tests were done and suspicions were confirmed. I had inherited an extremely rare disease called Hereditary Leiomyomatosis Renal Cell Cancer (HLRCC). ... / Evansville Courier & Press (subscription),
Bayer set to head along the acquisitions trail -- Jun 13, 2005
Bayer is also "very happy" with Phase III renal cell cancer test results for Sorafenib. For renal cell cancer and some other forms ... / MSN Money
FierceBiotech Honors Wilex AG as One of the “Fierce 15� ... -- Jun 21, 2005
...s lead compound Rencarex®, a targeted antibody therapy for the treatment of solid tumors, is currently in a pivotal Phase III trial in Renal Cell Cancer. ... / PharmaLive.com (press release),
Bayer "in-line" -- Jun 17, 2005
...note published this morning, the analysts mention that the peak sales of the company's Sorafenib drug, for the treatment of renal cell cancer, are expected to ... / New Ratings
TAT2005 - 3rd International Symposium on Targeted Anticancer ... -- Mar 4, 2005
Another highlight of the TAT 2005 program will be a Plenary Session on Friday, March 4 (8:30-10:30 hours) on emerging treatment options for renal cell cancer. ... / Medical News Today,
MethylGene Year End Results Conference Call Notice -- Mar 1, 2005
...trials. MG98 has entered a randomized two-step Phase II combination trial with interferon alpha in metastatic renal cell cancer. ... / PharmaLive.com (press release),
KARLA RICHES, 1955 - 2005 -- Feb 14, 2005
Feb. 11, at St. Luke's Medical Center in Milwaukee, Wis., of renal cell cancer. Her funeral service will be 10 am Tuesday, Feb. ... / Oskaloosa Herald,
Renal cell carcinoma, also known by the eponym Grawitz tumor, is the most common form of kidney cancer arising from the renal tubule. It is the most common type of kidney cancer in adults. Initial therapy is with surgery. It is notoriously resistant to radiation therapy and chemotherapy, although some cases respond to immunotherapy.
|
|
|
